JScope
Start free trial
Home / Projects / Pharma & medical
R&D facilityPharma & medical

Shikoku Chuken to build new headquarters and research facility in Ayagawa

Shikoku Chuken Co., Ltd.Ayagawa, KagawaPublished
InvestmentNot disclosed
PhasePlanned
Start—
CompletionJan 2028
To completion
Today
20272028

About 15 months to scheduled completion.

Shikoku Chuken will build a new headquarters facility on land adjacent to its existing headquarters in Ayagawa, Kagawa. The facility will expand research and development using clinical specimens and testing data collected from across Shikoku, along with corporate planning, information processing and administrative functions; operations are scheduled to begin in January 2028.

Project facts

Owner
Shikoku Chuken Co., Ltd.
Facility
R&D facility
Sector
Pharma & medical
Location
Ayagawa, Kagawa, Japan
Investment
Not disclosed
Scale / capacity
15 new employees
Completion
Jan 2028
Announced
Oct 1, 2026

Figures and schedules are as announced by the company or the public body concerned; plans can change. Amounts that were not disclosed are recorded as not disclosed, never estimated.

Also in Kagawa5 projects · ¥550M disclosedOn the map →

Rot Service to build new Takamatsu Kanan branch for freight warehousing and transportRot Service Co., Ltd.Planned¥550MShikoku Kasei Industries to establish advanced semiconductor materials production facility in SakaideShikoku Kasei Industries Co., Ltd.Plannedn/dDaikokuten Bussan to build new food processing center in KagawaDaikokuten Bussan Co., Ltd.Plannedn/dSamson to build new R&D building at Kannonji headquartersSamson Co., Ltd.Plannedn/d

Latest in Pharma & medicalAll Pharma & medical →

Fujifilm to install ADC raw-material manufacturing equipment at Hirono plant

NewPharma & medicalFukushimaPlanned

Fujifilm will install payload and linker-payload manufacturing equipment, including reaction vessels, a filtration dryer and a preparative HPLC system, at the Hirono plant in Fukushima. The facility will also add a laboratory for process and analytical-method development, with operations scheduled to begin in 2028, enabling Fujifilm's one-stop domestic ADC CDMO service.

Olympus completes new B Building at Nagano site for medical-device component production

Pharma & medicalNaganoCompleted¥18B

Olympus has completed the new B Building at its Nagano site in Tatsuno, Nagano, consolidating development and manufacturing functions and establishing a production base for key medical-device components. Construction began in February 2025, with full operation targeted for FY2026; the building has 17,665 sqm of total floor area and a total construction cost of approximately ¥18 billion.

JGC completes Chugai Pharma's UT3 biopharmaceutical API facility in Utsunomiya

Pharma & medicalTochigiCompleted

JGC Holdings completed the UT3 biopharmaceutical active pharmaceutical ingredient facility for Chugai Pharmaceutical Industry at its Utsunomiya plant in May 2026. The four-story facility supports clinical-trial manufacturing through initial commercial production and includes continuous-production capabilities, solar panels and other environmental features; it was handed over on May 14, 2026.

Lion to build new pharmaceutical plant in Hung Yen, Vietnam

Pharma & medicalHung YenPlanned¥1.5B

Lion has approved construction of a new pharmaceutical plant through its wholly owned Vietnamese subsidiary Merap Lion. The facility will produce prescription and over-the-counter solid-dose medicines, including tablets and granules, with operations planned to begin in the second half of 2030.